Arctoris co-founder & CEO Martin-Immanuel Bittner features in a short film about reproducibility and open data in drug discovery
OXFORD, UK – 19 June 2019 A short film about reproducibility and open data in drug discovery was officially released to the public in Berlin, Germany, at an event organised by the Young Academy of the German National Academy Sciences. The film stars Arctoris Co-Founder & CEO Martin-Immanuel Bittner speaking about his work at Arctoris and the wider drug discovery ecosystem.
About Arctoris Ltd
Arctoris Ltd is an Oxford-based research company that is revolutionising drug discovery for virtual and traditional biotechnology companies, pharmaceutical corporations and academia. Arctoris has established the world’s first fully automated drug discovery platform, offering pre-optimised and fully validated processes for its partners and customers globally. Accessible remotely, the platform provides on-demand access to a wide range of biochemical, cell biology and molecular biology assays conducted by robotics, enabling rapid, informed decision-making in basic biology, target validation, toxicology and phenotypic screening. These assay capabilities are accessed using a powerful online portal that streamlines experiment planning, ordering, tracking and data analysis. Thanks to the Arctoris platform, customers can rapidly, accurately and cost-effectively perform their research and advance their drug discovery programmes.
For more information, please visit www.arctoris.com or follow us on LinkedIn and Twitter.
For media enquiries, please contact:
Head of Office
READY TO GET STARTED?
To find out how to accelerate your project timelines and generate higher quality data, reach out to us today.